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Abstract Heart progenitor cells differentiate into various
cell types including pacemaker and working cardiomy-
ocytes. Cell-type specific gene expression is achieved by
combinatorial interactions between tissue-specific tran-
scription factors (TFs), co-factors, and chromatin
remodelers and DNA binding elements in regulatory
regions. Dysfunction of these transcriptional networks may
result in congenital heart defects. Functional analysis of the
regulatory DNA sequences has contributed substantially to
the identification of the transcriptional network compo-
nents and combinatorial interactions regulating the tissue-
specific gene programs. GATA TFs have been identified as
central players in these networks. In particular, GATA
binding elements have emerged as a platform to recruit
broadly active histone modification enzymes and cell-type-
specific co-factors to drive cell-type-specific gene pro-
grams. Here, we discuss the role of GATA factors in cell
fate decisions and differentiation in the developing heart.
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Congenital heart defects affect nearly one percent of live
births and are found in up to one-tenth of spontaneously
aborted fetuses [1, 2]. The development of the heart is
controlled by evolutionary conserved transcriptional net-
works. Genetic studies have identified mutations in genes
encoding transcription factors as well as proteins organiz-
ing the chromatin structure that are responsible for
congenital heart defects [3–5]. Defining the transcriptional
networks underlying normal heart development is a pre-
requisite for understanding the molecular basis of
congenital heart malformation. The specification of multi-
potent heart progenitor cells and their differentiation into
different cell lineages is under tight spatial and temporal
transcriptional control. Regulatory DNA elements (pro-
moters, enhancers, repressors, and insulators/boundary
elements) can interact with and respond to activating or
repressing transcriptional complexes (transcription factors,
activators, coactivators, repressors, and corepressors) to
mediate the temporal and spatial control of transcription.
Hence, functional analysis of DNA elements conferring
cell-type-specific gene expression is a good starting point
to identify the molecular mechanisms that underlie these
patterns of gene expression. Dissection and analysis of
regulatory DNA elements have led to the identification of
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many key regulators of the cardiac gene regulatory pro-
grams including the zinc finger TF Gata4. Mutations in
both GATA4 and its family member GATA6 in patients
have been associated with arrhythmias and defects in atrial,
ventricular, and AV septation [6–11]. In this review, we
will discuss the role of the GATA family of transcription
factors in heart gene regulation and differentiation.
Development of the chambers and the conduction
system
In vertebrates, the heart arises from cells in the anterior
lateral plate mesoderm of the early embryo (stage E7–7.5
in mouse). By E7.5–8.0, during folding of the embryo and
formation of the foregut, these cells migrate to the midline
to form the primary heart tube. The embryonic myo-
cardium of the tube is characterized by a primitive
phenotype, i.e., limited cell proliferation, a poorly devel-
oped contractile apparatus, and slow conduction [12, 13].
During further development, the heart tube elongates by
addition of progenitor cells to its poles. These cells are
referred to as second heart field progenitors that are kept in
an undifferentiated and rapidly proliferating state dorsal to
the primitive heart tube [14, 15]. Simultaneously, specific
regions in the embryonic heart tube acquire a chamber-
specific gene program, differentiate further, and expand by
rapid proliferation to form the ventricular and atrial
chamber myocardium ([E8.5). The chamber myocardium
acquires properties of fast conduction, and the contractile
apparatus starts to develop. In contrast, the regions flanking
these differentiating chambers, the sinus venosus, the
atrioventricular (AV) canal, and the outflow tract do not
differentiate or expand and consequently form constric-
tions. The AV canal preserves characteristics of the
embryonic myocardium of the tubular heart (Fig. 1),
including its slow conductive property, ensuring AV delay
of the impulse underlying the alternating contraction of the
atria and ventricles. Signals from the AV canal are crucial
for septation and valve formation, whereas the AV myo-
cardium itself forms the AV node and AV ring bundles of
the conduction system [16–18]. The fetal conduction sys-
tem can be subdivided into more compartments such as the
sinus node, the AV node, AV bundle, the left and right
bundle branches, and the peripheral ventricular system.
Each of these structures contains cardiomyocytes with
pacemaker activity and specific properties that discriminate
them from atrial and ventricular chamber myocardium.
Embryonic myocardial cells are confronted with a crit-
ical decision: differentiation into pacemaker-like
cardiomyocytes of the AV canal or into working car-
diomyocytes of the atrial and ventricular chambers. Bone
morphogenetic protein 2 (Bmp2) is expressed in the pri-
mary heart tube where it stimulates the expression of T-box
2 (Tbx2), required for the development of the AV canal
[17, 19, 20]. Both AV canal and chamber myocardium are
competent to respond to BMP signaling [21, 22]. However,
Bmp2 is selectively expressed in the AV canal myocardium
precursors and conditional deletion of the BMP type I
receptor ALK3 in the conduction system using specific Cre
driver mice (cGata6-Cre) demonstrated that BMP signaling
regulates the proper development of the AV conduction
system [23, 24]. Consistently, although the downstream
effector of BMP2, Smad4, is ubiquitously expressed at
E10.5, its localization (and transcriptional activity) is pre-
dominantly nuclear in the AV canal [25, 26]. Interestingly,
insertion of a transgenic construct harboring the AV canal-
specific enhancer of the chicken Gata6 (cGata6) in the
mouse genome leads to transgene activity in the cardiac
crescent (E7.5) where both Bmp2 and Tbx2 are expressed
[27, 28]. These observations, together with functional and
lineage tracing analyses for Tbx2, support the notion that
the AV canal myocardial cells are already specified at this





















Fig. 1 Schematic overview of heart development. The early heart
tube has an embryonic phenotype (gray). Chamber myocardium
(blue) expands from the outer curvatures, whereas non-chamber
myocardium (gray) of the inflow tract, atrioventricular canal, outflow
tract, and inner curvatures does not expand. a atrium, bb bundle
branch, ift inflow tract, la left atrium, lv left ventricle, pvcs peripheral
ventricular conduction system, ra right atrium, rv right ventricle, scv
superior caval vein
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More broadly expressed cardiac transcription factors
such as Tbx5, Tbx20, and Nkx2.5 are also required for the
development of the conduction system [31, 32]. Chamber
differentiation is suppressed by Tbx2 and Tbx3, which are
selectively active in the AV canal myocardium where they
suppress chamber-specific genes including Nppa (Anf,
atrial natriuretic factor), Gja1 (Cx43, connexin 43), and
Gja5 (Cx40, connexin 40) [33–35]. The sharp boundaries
between these two compartments are obtained by repres-
sive activities mediated by the Notch target genes Hey1 and
-2 [17, 36]. Hey1 is expressed in the atria and Hey2 in the
ventricles, but neither gene is found to be expressed in the
AV canal myocardium [36, 37].
Transcriptional activities of GATA factors
in mammalian heart development
The family of GATA transcription factors consists of six
members, Gata1-6. In vertebrates, most tissues of either
mesodermal or endodermal origin express one or more
Gata4-6 factor during development. In the primitive streak,
Gata4, -5, and -6 are detected in the precardiac mesoderm
(stage E7.5) [38, 39]. The expression patterns of Gata4 and
-6 have been reported to be identical throughout the pri-
mary heart tube (E8.0–8.5). As the tube loops (E8.5),
Gata5 becomes restricted to the endocardium, while Gata4
and -6 are maintained in the myocardium. Gata4 is
detected in the endocardium of the atria and ventricles and
endocardial cushions of the AV canal and outflow tract.
Gata4 and -6 are expressed in both the AV canal and
chamber myocardium, with no evidence for differential
expression levels and subcellular compartmentalization
[38, 40–43]. Since the spatial organization of the nucleus
may impact on activation or repression of gene expression
and interaction with co-factors, assessment of the local-
ization of GATA factors within the nucleus might be
relevant.
Mice null for Gata4 die between E8 and 9 because of
defects in heart morphogenesis and ventral closure of the
foregut. Aberrant heart formation in these mice is mainly
secondary to defects in the extra-embryonic and definitive
endoderm that affects migration and folding morphogen-
esis of the precardiogenic splanchnic mesodermal cells
[44–46]. Using a tetraploid embryo complementation
strategy, it has been possible to show that Gata4 is cell
autonomously required for cardiogenesis [47]. Elegant
functional analyses utilizing knockout ES cells and tissue-
specific disruption in mice unequivocally established a
role for Gata4, -5, and -6 in controlling heart development
that is consistent with their expression pattern. Studies
using heterozygous Gata4 and Gata6 mutants demon-
strated that both factors are critical for general cellular
processes including cardiac cell commitment, differentia-
tion, proliferation, and survival, hampering the analysis of
their function in the formation of structures that arise later
[9, 11, 48]. The levels of Gata4 and -6 are critical for
normal embryonic development and survival [9, 11, 48].
Embryos in which the expression of Gata4 protein in the
myocardium is reduced by 50 % survive. In contrast, a
reduction of 70 % causes fetal death between E13.5 and
16.5. These fetuses have AV canal defects, double outlet
right ventricle, and hypoplastic ventricular myocardium.
GATA6 mutations cause persistent truncus arteriosus in
human [49]. Gata6 also regulates morphogenetic pattern-
ing of the cardiac aortic arch [50]. Wnt2, a ligand
expressed specifically in the cardiac inflow tract, acts with
Gata6 to regulate the development of the atrial myo-
cardium, pulmonary veins, and AV canal [51]. Gata6 is
downregulated in Gata4 null mice and Gata6 null
embryos show down regulation of Gata4, indicating that
these factors cross regulate each other [44]. In addition,
Gata6 compensates the loss of Gata4 in inducing the
myocardial gene program [39, 48]. This transcriptional
interconnection is consistent with the observation that
Gata4 and Gata6 double heterozygote mice die very early
during embryonic development [48]. Gata4 and Gata6
mutants show defects of the venous pole region, suggest-
ing involvement of these factors in embryonic inflow tract
development and the venous blood connection [52]. Gata5
interacts with Gata4 and -6 in endocardial cushion for-
mation, i.e., morphogenesis of the atrioventricular valves
and outflow tract [53].
Gata4 is known to activate many cardiac genes dis-
playing regionally restricted expression, including the
chamber-specific genes Nppa and Nppb (Bnf, brain natri-
uretic factor) [54] and the contractile genesMyh6 (a-MHC)
and Myh7 (b-MHC) [55, 56]. Gata4 is shown to activate
the gene Gja5 (Cx40) [57] that plays an important role in
cell–cell communication in cardiomyocytes of the atrial
chambers and in the ventricular conduction system [58].
Gata6 activates the ion exchanger gene Ncx1 [59] and the
potassium channel gene Kv4.2 [60]. Expression of Nkx2.5,
one of the earliest markers of the cardiac lineage in ver-
tebrates, depends on GATA binding sites [61]. GATA
factors also control the expression of Mefc2c in outflow
tract and right ventricular myocardium [62]. Gata4 is a
direct transcriptional activator of cell cycle genes cyclin D2
and Cdk4. Gata4 physically and functionally interacts with
CDK4 [63] and is required for cardiomyocyte proliferation
[64]. Gata4 chromatin occupancy changes markedly
between fetal and adult heart, with only partial overlap in
binding sites [65]. This underlies the importance of rating
the quality of ChIP-seq experiments and the datasets gen-
erated in order to preclude incomparability due to low
quality.
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Interplay between GATA factors and chromatin
Approximately sevenmillion GATAmotifs are present in the
human genome [11]. This raises the question of which motifs
are occupied byGata4 in vivo.With the development ofChIP-
seq assays to assess Gata4 chromatin occupancy genome-
wide, it has becomeclear that only a small subset of theGATA
motifs are occupied in heart tissue, suggesting the existence of
a GATA recognition code that dictates site occupancy [66–
68]. HowGATA factors discriminate among these motifs in a
time- and location-dependent manner is unclear [69]. This
question directly applies to Gata4, and -6 in heart develop-
ment. An important consideration iswhether Gata4 andGata6
occupy identical or different WGATAR motifs in different
myocardial compartments. SinceGata4 and -6 have redundant
functions in regulating myocardial genes, addressing these
questions might well explain their possible similar participa-
tion in the conduction system and chamber gene programs.
Local chromatin environment, nearest neighboring factor
binding motifs and intrinsic features of the WGATARmotifs
are likely important parameters underlying the GATA
recognition code. The transcriptional activation domains of
Gata4, -5, and -6 are partially conserved, suggesting a similar
mechanism of transcriptional activation within this Gata
subfamily. Although Gata4, -5, and -6 bind a GATA or
GATA-like sequence element, their individual affinities for
various regulatory elements might also depend on flanking
nucleotide sequences or on interactions with co-factors and
other transcription factors. Gata4 ChIP-seq analyses also
revealed that a large fraction of genomic regions occupied by
Gata4 are not associated with a recognizable GATA binding
site, indicating indirect binding [66–68]. Consistent with this,
in vitro reporter assays suggest that Gata4 transcriptional
activities do not necessarily require Gata4 DNA binding [11].
Since ChIP assesses protein-DNA proximity by cross linking
and not by direct binding, it would be interesting to verify
GATA binding using in vivo foot printing. Assessment of the
genomic distribution of Gata4 and Gata6 occupancy by cell
sorted-based genome and proteome-wide technologies should
facilitate our understanding of how GATA factors select
chromatin target sites. This has become a realistic option with
the development of protocols to perform genome-wide anal-
ysis on small amounts of tissue [70–72].
There is no doubt that emerging molecular technologies
will help in understanding the function of GATA TFs in
cardiac lineage specification. GATA TFs regulate tran-
scription during differentiation by mediating long-range
DNA looping. Whether this is the case in the context of
heart development is unknown. Chromosome conformation
capture technologies (e.g., 3-5C, Hi-C) were developed to
identify long-range chromatin interactions [73]. The
ENCODE project has provided access to valuable data on
genome-wide chromatin occupancy of transcription factors,
chromatin-modifying and -remodeling enzymes, and his-
tone modifications in heart tissues [74]. Merging these
datasets can further facilitate identification of GATA reg-
ulatory elements. The functional importance of GATA
elements can be assessed in vivo using recent genome
editing technologies [75]. Recent ChIP-seq analyses show
that in the context of cardiac stress, Gata4 binds to a subset
of fetal genes such as Nppb [76] leading to the reactivation
of the ‘‘fetal gene program.’’ However, reactivation of fetal
genes constitutes a small portion of the transcriptional
response of the diseased adult heart [65]. ChIP-seq and
motif analysis have shown that the GATA motif is highly
overrepresented in Gata4-bound regions from fetal, adult,
and disease heart [65]. These analyses also indicate that the
selection of GATA binding sites is influenced by the
interaction of Gata4 with other TFs. The co-enriched motifs
of other TFs are rather distinct between fetal-specific and
adult-specific Gata4-bound regions. These changes are
associated with altered expression of transcriptional regu-
lators between fetal and adult heart. Interestingly, in
hypertrophic hearts, Gata4 regions contain an atypical
GATA motif and are enriched for the NFAT binding motif.
NFATs are essential mediators of cardiac hypertrophy.
From studies in cell culture, two distinct DNA binding
modes of GATA transcription factors have been deduced
[77]. In the wrapping mode, the two zinc fingers of a
GATA factor wrap around a palindromic GATA site,
cooperatively enhancing binding affinity and kinetic sta-
bility. In the bridging mode, a single GATA DNA binding
domain bridges two pieces of DNA. Because the DNA
binding domains of GATA proteins are highly conserved,
these structural features could be shared by all six GATA
family members. This may have important implications for
transcriptional regulation by GATA proteins. For example,
varying concentrations of GATA proteins during heart
development may not just affect their occupancy of DNA
but also could switch their DNA binding mode and affect
transcriptional networks. GATA proteins may loop DNA
through co-factors (e.g., Fog proteins) [78], which have
also been shown to play important roles in mediating DNA
loop formation [79–81].
Mechanisms underlying the function of governing the
decision of whether GATA TFs function as activators or
repressors of a targets gene have been studied in depth in the
context of the hematopoietic system. Using the aforemen-
tioned approaches, it has been shown that in this lineage
context, Gata1 uses Fog1 to activate and or repress the
majority of its target genes [82, 83]. Fog1 associates with the
repressive nucleosome remodeling and deacetylase NuRD
complex [84]. The transcription factor Gata1 is required for
terminal erythroid maturation and functions as an activator
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or repressor depending on gene context [85]. During late
erythroid development, PRC2 complex is involved in late
stages of silencing of some Gata1 repressed genes. The
Gata1-interacting coregulator Friend of Gata-1 (Fog1)
mediates Gata1-dependent activation and repression in a
context-dependent manner [82, 83]. Fog1 facilitates Gata1
chromatin occupancy and interacts with the repressive
nucleosome remodeling and deacetylase (NuRD) complex
[84]. GATA TFs in the context of the hematopoietic system
are known to cooperate with Brahma-related gene-1
(BRG1), an enzyme that disrupts chromatin structure, acting
as either an activator or a repressor in the SWI-SNF nucle-
osome remodeling complex [86, 87]. BRG1 could be a
privilegedmediator or partner in the action of cardiac GATA
factors on chromatin structure.
Chromatin remodeling enzymes regulate Gata4 target
genes by post-translational modifications of Gata4 [11, 88].
Gata4 physically interacts with histone acetyl transferases
(HATs) and histone deacetylases (HDACs) [89–91]. Acti-
vation of Gata4 is mediated through its acetylation by the
HAT p300 [92] which is consistent with the large proportion
of cardiac enhancers occupied by both [43, 65]. In turn, p300
also acetylates histones such as the histone 3 at lysine 27
(H3K27ac), a mark associated with active enhancers [93].
Gata4 cooperates with the acetylase p300 to deposit
H3K27ac at cardiac enhancers to stimulate transcription
[65]. Paradoxically, p300 occupies both GATA-activated
and -repressed genes [94, 95]. A large portion of Gata4
occupancy occurs at sites that have a closed chromatin
configuration in the normal heart [65]. HDAC1and HDAC2
can physically interact with Gata4 [89–91] and are func-
tionally redundant in the heart [96]. Gata4 forms a complex
with Hopx which serves as an adapter to facilitate HDAC2
recruitment, which in turn reduces Gata4 activity by
deacetylation [88]. The activity of GATA factors can also be
regulated through methylation. The polycomb-repressive
complex 2 (PRC2) directly binds and methylates Gata4,
reducing its interaction with and acetylation by the HAT
p300 [97]. This results in attenuation ofGata4 transcriptional
activity [97]. Given the interplay betweenGATA factors and
multiple coregulators, a system biology approach will be
required to develop a comprehensive model for the cardiac
transcriptional networks around the GATA factors.
GATA factors interact with other heart-expressed
transcription factors
GATA factors have a dual finger module which is highly
conserved among the six mammalian proteins. The C-ter-
minal finger mediates sequence-specific DNA binding,
while the N-terminal finger modulates DNA binding and
contacts DNA. The zinc fingers interact with multiple
coregulators. Disruption of these interactions has been
reported to underlie congenital heart defects [6]. A precise
balance between interactions with co-factors appears
essential for the regulation of their spatial and temporal
activity. It was previously demonstrated by in vitro and
in vivo studies that Gata4 and Tbx5 physically interact and
cooperatively activate endocardial [98] and myocardial
genes such as Nppa [6]. Gata6 and Tbx5 genetically
interact in vivo [40]. Combinatorial expression of Gata4,
Nkx2.5, and SRF (serum response factor) directs early
cardiac gene activity [66, 68, 99]. Although the Gata4 and
Gata6 protein interaction with the primary
myocardium/conduction system-specific protein Tbx3 has
not been firmly established, ChIP-seq data for Gata4 and
Tbx3 from heart tissue revealed a large portion of over-
lapping peaks, suggesting that Tbx3 and Gata4 might
cooperatively repress the working myocardial gene pro-
gram [67]. Gata6 regulates transcription of Id2 [100], a
transcriptional repressor involved in conduction system
lineage specification [31]. Gata4 and Smad4 form protein–
protein interactions and cooperatively regulate cardiac
valve development by regulating Id2 [101]. Further studies
will reveal whether Gata4 also activates Id2 in the con-
duction system and whether a Gata4/6-Smad4-Id2 network
module participates in the normal control of conduction
system gene expression and specification. Studies in post-
natal cardiomyocytes demonstrated that Gata4 and Gata6
can functionally interact with each other, at a single GATA
element, to synergistically activate the Nppa and Nppb
promoters [102]. Retinoic acid receptors regulate Nppa and
Nppb genes via direct interaction with Gata4 and its co-
repressor, Fog2 [103]. Mutations of Gata4 in human and in
mouse models can result in abrogation of physical inter-
action with some of these co-factors [104].
GATA factors and conduction system-specific
enhancers
DNA elements conferring cell-type-specific gene expression
are ideal to analyze the molecular mechanisms that underlie
the localized gene expression of conduction system genes.
For example, one of the enhancers that flank the cGata6 gene
directs transgene expression throughout the entire primary
heart tube and in all regions of primary myocardium that
persist at later stages (Fig. 2) [27, 43, 105]. Interestingly, this
enhancer module is completely inactivated in newly arising
chamber myocardium. Several other DNA elements con-
ferring AV-restricted patterns of gene activity have been
identified in mouse transgenic embryos, enhancers regulat-
ing Tbx2 [106], Tbx3 [107], Gjd3 (Cx30.2, connexin 30.2)
involved in conduction slowing [41], and the promoter of
cTnI [108]. Interestingly, the common features of these AV
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canal-specific regulatory elements are the presence ofGATA
consensus sequences and in vivo Gata4 occupancy as
demonstrated by recent ChIP studies [65, 67]. Moreover,
mutations in Gata4 and -6 are responsible for congenital
heart defects including AV canal defects and arrhythmias in
human andmouse [8, 11, 41, 109], implicating their function
in conduction system tissues [100, 110–113]. Conduction
system-restricted gene activity is controlled bymore broadly
expressed transcription factors. We and others have shown
that the activity of these AV canal-specific regulatory ele-
ments depend on GATA binding sites [41, 43, 105]. The
activity of the Gjd3-AV canal enhancer also depends on the
broadly expressed factor Tbx5 [41]. Gata4, Tbx5, and
Nkx2.5 are expressed in largely overlapping domains in the
conduction system and co-occupy several conduction system
gene loci [67]. This suggests that they may cooperatively
activate genes in the conduction system [114]. Despite
widespread expression throughout the myocardium, these
factors have a specific role in patterning the AV conduction
system.
How do GATA factors acquire their AV canal-
specific functions?
The emergence of cell sorting-based transcriptomics and
ChIP-seq is contributing to a better understanding on how
GATA factors acquire specific functions. By integrating a
variety of ChIP-seq datasets, we found that Gata4 binds to
loci associated with both active and repressive chromatin
signatures [43]. We tested whether the AV canal-specificity
of these enhancers involves a mechanism of repression
outside the AV canal. The promoter of the rat cardiac
troponin T (cTnT, Tnnt2) gene drives efficient pan-cardiac
expression in transgenic mice [115]. Previously identified
AV canal enhancers were coupled to the cTnT-lacZ trans-
genic construct, and a repressive function was assayed in
mouse transgenic embryos.
Analysis of ChIP-seq data from tissue-specific com-
partments coupled with validation in transgenics revealed
these AV canal enhancers act as cell-type-specific
switches, activating transcription in the AV canal and
repressing transcription in the chambers. We found that
mutation of the GATA binding sites affected the repressive
activity of the cGata6 and Tbx2 enhancers. Thus, GATA-
dependent AV canal-specific enhancers mediate both
region-dependent gene activation and repression. Gata4
activates such enhancers in synergy with Bmp2/Smad
signaling. Our data indicated that GATA sites within AV
canal-specific regulatory regions recruit a Gata4-Smad4-
HAT p300 transcriptional activation complex. This is
associated with AV canal-specific acetylation of histone
H3K27.
In chamber myocardium, Gata4 represses these enhan-
cers through pan-cardiac HDACs and chamber-specific
Notch target genes Hey1 and -2 [43]. The cGata6, Gjd3,
and cTnI modules do not contain a consensus Hey binding
site (i.e., E-box), suggesting that Hey factors mediate
repression via GATA protein interaction [116]. We spec-
ulate that Gata4-HDAC mediated deacetylation of H3K27
serves as a mode of confinement of the conduction system
gene program, preventing its activity in the chambers.
Interestingly, histological analysis revealed that Tbx2
expression was only slightly expanded in Hey1 and Hey2
double-deficient mice [117]. This implies that Hey1 and -2
refine the boundary between the AV canal and the cham-
bers by repressing Tbx2 [36]. These factors contribute but
are not essential for chamber repression by Gata4-HDACs.
GATA sites in the AV canal regulatory elements thus
serve as a platform to recruit broadly active histone mod-
ification enzymes and localized co-factors to drive AV
canal-specific gene activity (Fig. 3). Obviously, post-
translational modifications could play a role in this process
such as direct acetylation/deacetylation of Gata4, -6 pro-
teins accompanied by methylation by the aforementioned





Fig. 2 Tandemly repeated copies of a 102 bp cGata6 enhancer
fragment drive expression in the developing AV canal at stage E9.5; a









Fig. 3 Cartoon depicting the overlapping expression patterns of
Gata4, broadly active histone modification enzymes, localized co-
factors, and the level of H3K27ac enrichment on AV canal gene loci
at stage E9.5–E10.5, atr atria, vent ventricles
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PRC2 complex. Whether a change of GATA factor con-
centrations guide this dual function is unknown. Since
inspection of Gata4, Bmp2, and cGata6-lacZ expression
patterns revealed that they are already expressed in the
cardiac crescent, it suggests that already at the primitive
streak stage, the GATA-Smad-HAT complex may occupy
primary myocardial gene loci. This could lead to acetyla-
tion of H3K27 at this early stage. Subsequently upon
chamber formation, these loci may become deacetylated in
cells receiving appropriate local guidance cues.
Perspectives on the requirement of GATA factors
to reprogram pacemaker cell identity
Disease, aging, or gene defects may cause conduction
system dysfunction, a common cardiac disorder that cur-
rently requires the implantation of an electronic
pacemaker. Recent advances in the stem cell field indicate
that the creation of induced pacemaker cells may offer a
promising alternative to repair diseased pacemaker myo-
cardium [118]. Developmental and genetic studies have
identified several cardiac transcription factors that are
necessary for the development of the conduction system
[13]. Currently, there is interest in using this information to
reprogram cells to pacemaker cells by transducing TF
genes [119]. In vitro direct reprogramming of human
fibroblasts toward a cardiomyocyte-like cell type requires a
minimal cocktail of transcription factors that include Gata4
[120, 121]. However, in vitro reprogramming remains
inefficient and better understanding of epigenetic changes
associated with TF overexpression may provide clues for
improving the efficiency [122]. A key question is how
factors such as Gata4 could enable cellular reprogramming.
Gata4 occupancy does not necessarily imply that it acti-
vates transcription. Nevertheless, its occupancy seems to
initiate a series of changes that allow the enhancer to
recruit its full set of transcription factors and chromatin
remodeling complexes. At a particular stage in differenti-
ation, some transcription factors, defined as ‘‘pioneer
factors,’’ are able to access DNA target sites in chromatin
where other factors are not yet able [123]. These factors
can recruit chromatin modifiers and activate or repress
transcription. Similarly, Gata4 has been proposed to initiate
formation of transcriptional regulatory complexes on
closed chromatin [124]. Later during differentiation and
depending on the context such as the presence of binding
sites for other transcription factors, an enhancer may
become associated with active histone marks such as the
H3K27ac or with repressive marks and the poised RNA pol
II complex. As development continues, we and others have
shown that the binding of additional factors or changes in
cofactor availability may change the activity of the targeted
element. This change of activity occurs when the binding
of the priming factor is maintained which enables a rapid
transcriptional response to inductive signals. In the lineage
conversion of one cell type to another, overexpression of
GATA factors may actively open-up the local chromatin
and make it competent for other factors to bind.
In many of the reprogramming studies, multiple factors
are required for the cellular conversion, emphasizing the
role of cooperativity among factors in the starting popu-
lation of cells. Binding cooperatively could be sufficient to
simultaneously engage a target site in chromatin and acti-
vate gene expression. Stoichiometry of Gata4 and its co-
factors influences the efficiency and quality of cardiomy-
ocyte reprogramming [125]. Although the methods using
this cocktail of cardiac transcription factors provided the
proof of concept that somatic cells can be reprogrammed
into cardiomyocytes, reprogramming toward specific
human cardiac subtypes is a remaining challenge. More-
over, only a small subset of the targeted cells becomes
Gata4 Nkx2.5 Tbx5 






Fig. 4 Working model of a GATA factor regulatory network for
primary versus chamber myocardium formation. GATA elements
direct complex formation of cardiac transcription factors, broadly
active histone modification enzymes, and localized co-factors to drive
specific gene activity. GATA and other broadly expressed transcrip-
tion factors cooperatively activate chamber genes in the chambers and
AV canal genes in the AV canal. Locally expressed Tbx2/3 and
GATA factors cooperatively repress the working myocardial gene
program in the AV canal/primary myocardium. GATA binding site
enhancers recruit a Gata4/Smad4/HATp300 transcriptional activation
complex in the AV canal and a Gata4/Hey1,2/HDACs transcriptional
repression complex in the chambers, which coordinately establish AV
canal-specific gene expression. Broadly expressed, primary- and
chamber-specific transcription factors are depicted in black, gray, and
blue, respectively
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reprogrammed in vitro. Inhibitors of histone-modifying
enzymes are known to enhance reprogramming, suggesting
that modulation of these chromatin-modifying enzymes
may be exploited to more efficiently generate induced
pacemaker cells [126–128]. In this regard, it remains to be
determined whether manipulating the GATA-Smad-HAT/
GATA-Hey-HDAC complexes could target many silent
conduction system-specific sites, open the chromatin for
active transcription and enhance the reprogramming
toward human pacemaker cells efficiently.
In summary, the cooperation of GATA factors with
active histone modification enzymes and localized co-fac-
tors ensures proper spatial–temporal expression of cardiac
genes during normal embryonic development (Fig. 4).
Defining how GATA or GATA-co-factors act in different
myocardial compartments to enable epigenetic regulatory
events will provide insight into the biology of progenitor
cells leading to methods for increasing the efficiency of
directed differentiation of pluripotent cells and cellular
reprogramming into myocardial subtypes. Addressing this
question is also critical for understanding the origin of
congenital heart defects.
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